Podcasts about human papilloma virus hpv

The Department of Health will launch the 2026 Human Papilloma Virus (HPV) vaccination drive today, targeting girls aged 9 and older, mainly in Grade 5, to protect them from cervical cancer. Over 5,700 cases of cervical cancer are reported annually in South Africa, with more than 3,000 deaths. Unvaccinated girls and women with HIV face higher risks. For more on the vaccination roll out, Elvis Presslin spoke to Dr. Fikile Ndlovu, Deputy Director General for HIV, TB, Maternal and Child Health at the Department of Health

January is observed as Cervical Cancer Awareness Month and therefore the Ministry of Health, Wellness and Nutrition has renewed its commitment to ending cervical cancer as a public health problem—an achievable goal when we vaccinate, screen, and treat in a timely and equitable way. Saint Lucia has already made meaningful strides towards elimination targets and has seen increased HPV coverage in girls and boys aged 11-12 years. The Ministry of Health has also improved its access to screening, care and follow-up for cervical cancer. There has been increased screening of women at the primary healthcare level – an engagement that we will continue to strengthen. Cervical cancer screening is now offered under Universal Health Coverage (UHC) with Human Papillomavirus (HPV) testing and liquid-based cytology (LBC) being made available island wide. Services are available, with a strong focus at the primary care level. Cervical cancer prevention and early detection services are offered throughout the health system, with Primary Care and Community Wellness Centres playing a central role. This month, the Ministry of Health will continue focused action to expand coverage, improve screening quality and follow-up, and ensure that every woman can access prevention, early detection, and care.

As part of the TMM4950 Sci-Comm special episode, J.P. Doyle from the University of Ottawa interviews Dr. Alexandre Stewart, a distinguished scientist from the University of Ottawa Heart Institute and a director of the Laboratory of Translational Genomics. In this episode, Dr. Stewart and J.P. discuss the viral origins of breast cancer, specifically the hypothesis that the Mouse Mammary Tumor Virus (MMTV) may cause breast cancer in humans. They explored the "second hit" hypothesis, geographic variations in cancer incidence between Western and Eastern Europe, and the potential for future vaccines and anti-retroviral therapies to prevent and treat the disease.Learn more about Dr. Stewart: https://www.ottawaheart.ca/profile/stewart-alexandreRead more about the paper: https://doi.org/10.3390/v140305590:10 - Introduction to Dr. Alexandre Stewart and Breast Cancer1:04 - Inspiration: The Biology of Breast Cancer and Immunosuppression2:48 - Geographic Variation and the Migrant Effect4:25 - Mechanisms: How MMTV and Human Papillomavirus (HPV) differ in causing cancer7:05 - The Senegal Study: Globalization and Mouse Populations10:22 - Vaccines and Anti-Retroviral Parallels14:34 - ConclusionMusic Credit: This podcast episode features the song 'Documentary' by SigmaMusicArt (Mikhail Smusev) via Pixabay, available under the Pixabay Content License. Listen more:https://pixabay.com/music/modern-classical-documentary-264400/J.P. Doyle (Host, Content Writer), Barry Ngo (Producer, Editor, Promoter)

Human Papillomavirus, or HPV, is responsible for 6 different kinds of cancers…Cervical, anal, oral pharyngeal, vaginal,  vulvar,  and penile. So, it was a big deal when the HPV vaccine was approved in 2006 females between the ages of 9 and 26.   In 2018, the age range was expanded to include adults up to the age of 45. But, what about women over 45? Shouldn't they have the option of getting a vaccine that prevents 90% of HPV related cancers?  My guest is Dr. Vivien Brown, an Assistant Professor at the University of Toronto with a special interest in Adult Immunization and Vaccine Preventable Illness.  Dr. Brown presented HPV initiatives in Canada at the UN meetings for the Commission on the Status of Women.  Background on the Human Papilloma Virus (HPV) vaccine and HPV  Cancers associated with HPV Who should get HPV vaccines Why it is best to vaccinate young girls and boys If women with cervical cancer should still get vaccinated If people who got the original vaccine with 4 serotypes, should get the newer vaccine with 9 serotypes How much the vaccine reduces the risk of cancer Side effects of the vaccine Why the vaccine was expanded from age 26 to age 45 Vaccine efficacy is less in older women How HPV is transmitted in older women Time of exposure of HPV to cancer Reasons that women over the age of 45 are at risk of exposure to HPV The case for universal vaccinations and STI screening If MEN are (should) getting vaccinated over age 45 If women should get tested for previous infections before getting vaccinated Why Canadian dentists are now counseling and administering HPV vaccinating  If single women in their 60s should get vaccinated if they are not sexually active and have no plans for sexual activity Other vaccines recommended in older women Tetanus Pneumonia Influenza Shingles RSV Covid If it's OK to get tvaccines all at once or if dosing should be divided The Case for Seeing a Gynecologist No Matter How Old You Are                                      Vivien Brown MDCM,*CCFP, MSCP Dr. Vivien Brown, is a family physician and Assistant Professor, Department of Family & Community Medicine, University of Toronto, is renowned for her expertise in women's health, brain health, immunization, health promotion and healthy aging. *MDCM stands for Medicinae Doctorem et Chirurgiae Magistrum, which translates to "Doctor of Medicine and Master of Surgery" in Latin. It is a medical degree awarded by McGill University in Montreal, Canada.  Dr. Streicher is on SUBSTACK      DrStreicher.Substack.com Articles Monthly newsletter All COME AGAIN podcast episodes Monthly News Flash Reports on recent research  Monthly Zoom Ask Me Anything Webinar    Information on Dr. Streicher's COME AGAIN Podcast- Sexuality and Orgasm   Lauren Streicher MD, is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, the founding medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause, and a Senior Research Fellow of The Kinsey Institute, Indiana University. She is a certified menopause practitioner of The Menopause Society.  Dr. Streicher is the medical correspondent for Chicago's top-rated news program, the WGN Morning News, and has been seen on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBCNightlyNews,20/20, and World News Tonight. She is an expert source for many magazines and serves on the medical advisory board of The Kinsey Institute, Self Magazine, and Prevention Magazine. She writes a regular column for The Ethel by AARP and Prevention Magazine.    LINKS Subscribe To Dr. Streicher's Substack Information About the COME AGAIN Podcast Dr. Streicher's CV and additional bio information To Find a Menopause Clinician and Other Resources  Glossary Of Medical Terminology     Dr. Streicher's Inside Information podcast is for education and information and is not intended to replace medical advice from your personal healthcare clinician. Dr. Streicher disclaims liability for any medical outcomes that may occur because of applying methods suggested or discussed in this podcast.                                 

Human Papillomavirus (HPV) is a small DNA virus that infects skin and wet surfaces of the body. The virus is typically spread through vaginal, anal, or oral sex. There are over 100 different types of HPV. The most common types of HPV are found on the skin and appear as warts. It is one of the most common types of sexually transmitted infections worldwide. HPV is responsible for more than 90% of anal and cervical cancers. The high-risk types of HPV form in the back of the throat, also known as Oropharyngeal Cancer. Vivian F. Wu, MD, MPH, is a surgeon-scientist specializing in all cancers of the head and neck, including those of the tongue, throat, voice box, thyroid, skin, and salivary glands. She is the Director of the Head and Neck Cancer Center of Excellence at Saint John's Cancer Institute and Pacific Neuroscience Institute (PNI).

In May 2024, the FDA approved vaginal self-collection for HPV as a cervical cancer screening tool. This was limited to health care settings. While this self collection option can help address some of the emotional deterrents to a speculum examination, it fails to overcome the remaining substantial clinic access barriers cited among those who are underscreened, including time off work, arrangement of child or elder care, and transportation. Then, the FDA approved the first at-home cervical cancer screening test on May 9, 2025. This test, called the Teal Wand (FDA-approved prescription device), allows individuals to self-collect vaginal samples at home to test for Human Papillomavirus (HPV). But is at-home testing valid? Does this work? A new publication in JAMA Network Open (May 19, 2025) answers this important question. Listen in for details.

What if chronic diseases like cancer and Alzheimer's are caused by infections we've overlooked? We assume chronic disease is caused by genetics and / or lifestyle. However, evolutionary biologist Dr. Paul Ewald says latent viruses and pathogens play a critical hidden role in many diseases. For example, we already know that Human Papillomavirus (HPV) causes cervical cancer. And research indicates how the EBV virus shows up in Multiple sclerosis, and chlamydia pneumonia shows in Alzheimer's. Deeper investigation into viruses and disease is warranted and will help with better diagnosis and treatment.Dr. Paul Ewald is also the author of Plague Time: The New Germ Theory of Disease, and Evolution of Infectious diseases. Episode Show Notes: https://livelongerworld.com/p/pewaldFind me: https://x.com/aasthajs My longevity products: https://www.livelongerworld.com/p/2024TIMESTAMPS:0:00 Role of infection in chronic disease is neglected2:40 Role of viruses in Alzheimer's10:50 Connections between Alzheimer's, diabetes, cardiovascular disease15:57 Genes cannot explain the full reason for disease20:47 Strong association between Alzheimer's, chlamydia pneumonia, and APOE428:16 Multiple sclerosis and EBV virus35:08 Latent viruses may in fact be active & cause cancer41:41 Sexually- transmitted pathogens correlated with cancer46:50 Viruses that cause cancer (EBV & breast cancer)53:09 Hodgkin's lymphoma and virus57:15 Stanford study showing EBV as leading cause of MS1:00:19 Do viruses attack the mitochondria and cause cancer1:01:38 Glioblastoma and virus / antiviral treatment1:07:07 Virus vs. oncogenes causing cancer1:14:17 Breast cancer BRAC1 mutations & virus association1:15:59 Vaccines against viruses1:17:56 Practical steps if you test positive for infectious viruses1:24:57 Could cancer relapse be due to persistent virus1:27:48 Protect the immune system1:29:38 Areas Dr. Ewald is excited aboutAASTHA, LIVE LONGER WORLD:X: https://x.com/aasthajs Newsletter: https://livelongerworld.com/Instagram: https://www.instagram.com/aasthajs/PAUL EWALD LINKS:Plague Time: The New Germ Theory of Disease: https://amzn.to/3FXjOSuEvolution of Infectious diseases: https://amzn.to/3FYaqOvEpisode Show Notes: https://livelongerworld.com/p/pewaldALSO WATCH:Keto & Metabolic Therapy for Cancer | Dr. Thomas Seyfried: https://open.spotify.com/episode/7tYdjcJ3G4tqbAx9Z6Bix2?si=biOOH1e5RpeZduLJv2fPHw

“Primary care physicians are your first line of defense against cancer,” said Matthew Farrell, M.D., an Ohio State Wexner Medical Center primary care physician and a clinical associate professor of family and community medicine. Prevention, screenings and early detection are crucial and begins with a patient's family history with cancer and other medical issues. “We are thorough and ask about their first-degree relatives, their parents, siblings and children, and their secondary relatives, such as grandparents and aunts and uncles,” Farrell said. “If I see a pattern, a certain number of relatives with the same cancer, especially at an early age, there could be a genetic factor.” A patient with an inherited genetic mutation will then be screened at an earlier age and more often. Dr. Farrell also talked about the importance of children receiving the Human Papillomavirus (HPV) vaccine that prevents certain types of cancer. He examines patients to detect skin cancer and melanoma in the early stages. “Skin cancer is the most common form of cancer and it's personal for me; my mother was diagnosed with melanoma three times … and she's doing fine.” Breast cancer and prostate cancer are two of the most common forms of cancer. Dr. Farrell discussed when women should begin getting yearly mammograms, and why and when men should begin to undergo regular Prostate-Specific Antigen (PSA) tests. Men and women without a family history of colorectal cancer should get their first colonoscopy at 45. “My brother-in-law was 52 when he had his first colonoscopy,” Dr. Farrell said. “They found a large tumor in his colon; it was removed, and he's been cancer free for 20 years now.” Lung cancer screenings are relatively new and recommended for long-time smokers. They are vital because “if you wait until there are symptoms it's very hard to treat and cure,” Dr. Farrell said, adding “I'm fortunate to be part of the Ohio State system and the James where we have experts and specialists for every type of cancer and medical issue my patients have.”

On International HPV Awareness Day, Dr. Nicola Paul hosts Dr. Tando Gaqana, a passionate HPV vaccine advocate, and Daniel Mora-Brito, IQVIA's thought leader in global health, to discuss the impact of Human Papillomavirus (HPV) in South Africa, highlighting the importance of vaccination and regular screening to prevent HPV-related conditions in Africa.

In honor of Cervical Health Month, Dr. Janice Enriquez talks with Dr. Marguerite Brathwaite about cervical cancer screening and women's health. She explains that cervical cancer screening involves Pap smears to detect abnormal cervical cells and Human Papillomavirus (HPV). Dr. Brathwaite emphasizes the importance of regular screenings and safe sex practices to prioritize cervical health.

Episode 182: HPV VaxFuture Dr. Zuaiter and Dr. Arreaza briefly discuss HPV infection but pocus on the prevention of the infection with the vaccine. Dr. Arreaza mentions that HPV vaccine is also recommended by ASCCP to medical professionals. Written by Amanda Zuaiter, MS4, Ross University School of Medicine. Edits and comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Human Papilloma Virus (HPV).According to the World Health Organization, cervical cancer is the 4th most common cancer affecting women globally. Annually, there are over 600,00 new cases and more than 300,000 deaths. The leading cause of cervical cancer is HPV. HPV, or human papillomavirus, is a prevalent virus that is spread through close skin-to-skin contact, mainly by sexual intercourse. It is the most common sexually transmitted disease in the United States. The term STI and STD are used indistinctively, but some people make a difference, such as Dr. Cornelius Reitmeijer. STI refers to sexually transmitted infection, which can be asymptomatic, and STD stands for sexually transmitted disease, which are the signs and symptoms caused by the multiplication of the infectious agent and disruption of bodily functions. STI is the preferred term, as recommended by experts during the last few years.  Low risk vs High risk HPV.There are over 200 strains of HPV which fall into two categories: low risk and high risk. The low-risk types, HPV 6 and 11, cause warts around the genitals, anus, mouth or throat. The high-risk types, HPV 16 and 18, are linked to cervical, vaginal, anal, and other cancers. Persistent infection with high-risk HPV types is the primary cause of cervical cancer, accounting for 70% of cervical cancer cases. While often asymptomatic, persistent HPV infections can develop into papular lesions which can cause bleeding and pain or cause sore throat and hoarseness if warts develop in the throat.Not all warts will turn into cancer, but the risk of a wart turning into cancer is higher than normal skin or mucosa that has not been infected by HPV.Even though cervical cancer is the most well-known condition linked to HPV, it's important to note that HPV isn't just a women's health issue. It can also cause cancers in men, such as throat, penile and anal cancers. Men, however, are not screened for HPV if they have no signs or symptoms of infection.HPV Prevention: General measures that can be taken are maintaining a healthy immune system by exercising regularly and a balanced diet and quitting smoking.Male circumcision has been shown to reduce the risk of penile cancer in men and their sexual partners may have a lower risk of cervical cancer. Screening: Women should undergo regular pap smears with HPV screening. Pap smear screening begins at the age of 21 and is recommended every 3 years. From ages 30-65, co-testing should be done every 5 years, according to the guidelines by the American College of Obstetrics and Gynecology. Also, HPV test self-collection is now available in the US since May 2024, and it is useful especially in rural areas.The most effective ways to prevent the transmission of HPV is to practice safe sex, using condoms, and getting vaccinated. HPV vaccine. For medical providers: It was announced only to ASCP (American Society for Colposcopy and Cervical Pathology) members in the middle of the pandemic. On February 19, 2020, ASCCP recommended HPV vaccination for clinicians routinely exposed to the virus.This recommendation encompasses the complete health care team, including but not limited to, physicians, nurse practitioners, nurses, residents, and fellows, as well as office and operating room staff in the fields of obstetrics and gynecology, family practice, gynecologic oncology, and dermatology. Let's remember that in 2018, the FDA a supplemental application for Gardasil 9 to include persons aged 27 to 45 years old. The ASCCP letter states “While there is limited data on occupational HPV exposure, ASCCP, as well as other medical societies, recommend that members actively protect themselves against the risks” among medical providers. For patients: The vaccine is given to prevent the types of HPV that are most likely to cause cancer and other health problems. It works by training the immune system to recognize and fight HPV before an infection can take hold. Gardasil-9® is the brand name that is offered in the US. The 9 means it targets 9 strains of the virus (6, 11, 16, 18, 31, 33, 45, 52, and 58). It's important to note that the vaccine is preventative, and it is not considered a treatment. This means it's most effective when given BEFORE any exposure to HPV, ideally during adolescence. The HPV vaccine is recommended for boys and girls ages 11-12 but can be started as early as the age of 9. We need to be prepared to manage vaccine hesitancy because some parents may be concerned when you explain the vaccine to them. A study done in Scotland found that there were NO cases of invasive cervical cancer in adults who received any doses of the HPV vaccine at 12 to 13 years of age. To get to that conclusion, they reviewed the cancer data of 447,845 women who were born between 1988 and 1996. The data demonstrated that the HPV vaccine prevents invasive cervical cancer, especially when given between 12 to 13 years of age. When the vaccine is given later in life, it tends to be less effective. AmandaHow is HPV vaccine given?The vaccine schedule is as follows: -For ages 9-14, two shots are given with the second dose 6-12 months after the first. -For those ages 15-26, three shots are given. After the first shot, the second is given after 1-2 months, and the third shot 6 months after the first. This is the same schedule for immunocompromised people regardless of their age. -People over the age of 26 can still receive the vaccine, as the FDA has approved the vaccine for individuals up to the age of 45. With that being said, those over the age of 26 may not fully benefit from the vaccine due to the fact they may have already been exposed to HPV. Still, vaccination can provide protection against other strains of the virus.Other HPV Vaccine considerations:Is HPV vaccine effective?-Studies have shown that the HPV vaccine is nearly 100% effective at preventing cervical pre-cancers caused by HPV 16 and 18.Are boosters needed?-The vaccine provides protection for at least 10 years and boosters are not required. The vaccine is recommended for boys too, as they are also at risk for HPV causing cancers, and administration of the vaccine helps to reduce the spread of the virus. It is safe to administer the HPV vaccine with all other age-appropriate vaccinations. What if my patient misses a dose?-If a dose is missed, it can be resumed at any time without restarting the series. There are no known severe side effects or reactions to the vaccine. The vaccine can be given even if the person has already been exposed to HPV as it can protect against the other types of HPV.Conclusion: HPV is a common cause of cervical cancer, and the benefits of the HPV vaccine are profound. Countries with high vaccination rates have already seen significant drops in HPV infections, genital warts, and cervical pre-cancers. Vaccination protects individuals and helps achieve herd immunity, benefiting entire communities.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Sabour, Jennifer, “The Difference Between STD and STI,” Verywell Health, August 22, 2024, https://www.verywellhealth.com/std-vs-sti-5214421. ASCCP Letter, February 19, 2020, https://www.asccp.org/hpv-vaccinationBarry HC. Scottish Screening: No Cases of Invasive Cervical Cancer in Women Who Received At least One Dose of Bivalent HPV Vaccine at 12 or 13 Years of Age. Am Fam Physician. 2024 Aug;110(2):201-202. PMID: 39172683. https://pubmed.ncbi.nlm.nih.gov/39172683/World Health Organization. “Cervical Cancer,” March 5, 2024, www.who.int/news-room/fact-sheets/detail/cervical-cancerACOG, “Cervical Cancer Screening FAQ,” www.acog.org/womens-health/faqs/cervical-cancer-screening. Accessed January 9, 2025.ACOG, “HPV Vaccination FAQ,” www.acog.org/womens-health/faqs/hpv-vaccination. Accessed January 9, 2025.Cox, J. Thomas and Joel M Palefsky, UpToDate, www.uptodate.com/contents/human-papillomavirus-vaccination, accessed January 9, 2025.National Cancer Institute. “HPV and Cancer.” National Cancer Institute, 18 Oct. 2023, www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer .Theme song, Works All the Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Alessandro Santin to discuss Sacituzumab Govitecan (TROPiCS—03) in Advanced Endometrial Cancer. Dr. Alessandro D. Santin, a native of Italy, graduated with honors from the University of Brescia, Italy and received his postgraduate training in Obstetrics & Gynecology at the same University. He served a fellowship in Gynecologic Oncology at the University of California, Irvine and an International Fellowship in the Division of Gynecologic Oncology at the University of Arkansas for Medical Sciences, Little Rock, Arkansas. Dr. Santin joined the faculty in the Section of Gynecologic Oncology in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale University as Professor as of July 2008. Dr. Santin has more than 400 original research and peer-reviewed publications including multiple review articles and book chapters and he has written extensively on various topics, including cancer of the ovary, endometrium and cervix as well as on tumor immunology and immunotherapy. Dr. Santin's clinical interests include the use of immunotherapy in ovarian, cervical and endometrial carcinoma patients with disease resistant/refractory to standard treatment, therapeutic vaccines against Human Papillomavirus (HPV) infected genital tumors, and the development of personalized treatment modalities including monoclonal antibodies and antibody-drug-conjugates (ADC) against chemotherapy resistant gynecologic tumors. Highlights: In the TROPiCS-03 trial Sacituzumab Govitecan demonstrated encouraging clinical activity in recurrent endometrial cancer patients in progression after chemotherapy and immune check point inhibitors Sacituzumab Govitecan toxicity profile was manageable with only 5% of patients discontinuing treatment due to TRAEs TROP-2 protein was expressed in over 90% of endometrial cancer patients enrolled in the TROPiCS-03 trial and showed limited correlation with efficacy to Sacituzumab Govitecan

On episode #66 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 10/8 – 10/23/24. Host: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile Samples in Young Men in Denmark: Results 10 Years After Implementation of a Girls-Only HPV Vaccination Program (JID) Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America (CID) Bacterial Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation (LANCET: Infectious Diseases) Time to turn off the toxins: adjuvant suppression of group A streptococcus (LANCET: Infectious Diseases) Comparing rates of recurrent infection for first occurrence of Clostridioides difficile between tapered oral vancomycin and standard vancomycin: a retrospective, propensity matched cohort study(Infection Control and Hospital Epidemiology) Evaluation of primary oral vancomycin prophylaxis against C. difficile infection during autologous stem cell transplantation (OFID) Oral Vancomycin to Prevent C. difficile in Stem Cell Transplant Recipients: The last frontier in antimicrobial prophylaxis (OFID) First Report of a Fatal Septicemia Case Caused by Vibrio metoecus: A Comprehensive Functional and Genomic Study (JID) Fungal The Last of US Season 2 (YouTube) A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group(PLoS Neglected Tropical Diseases) Epidemiological and clinical features of a large blastomycosis outbreak at a paper mill in Michigan (CID) Do morphogenetic switching and intraspecies variation enhance virulence of Candida auris? (PLoS Pathogens) Parasitic Beyond Human Babesiosis: Prevalence and Association of Babesia Coinfection with Mortality in the United States, 2015–2022: A Retrospective Cohort Study (OFID) New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine (LANCET: Infectious Diseases) Miscellaneous Social and Environmental Benefitsof Pediatric Infectious Disease Telemedicine (Journal of the Pediatric Infectious Diseases Society) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

In this episode Dr. Kharrazian explores the world of chronic infections, such as Epstein-Barr Virus (EBV), Hepatitis C, Covid, and Human Cytomegalovirus (CMV), and their impact on our immune system. He explores how some pathogens hide within our bodies and reemerge when our immunity is compromised.He discusses the latest research linking these infections to autoimmune diseases and even cancer, and emphasizes the importance of enhancing our immune defenses rather than just relying on antiviral treatments. He covers a wide range of topics from the basics of virology, the dynamics of long COVID, and the sobering realities of Hepatitis C and Human Papillomavirus (HPV), to the ripple effects of viral infections on our overall health.Learn more at drknews.comFor patient-oriented courses, visit https://drknews.com/online-courses/For CE and CME practitioner courses, visit https://kharrazianinstitute.com/00:00 MHC proteins activate cells to fight infection.06:16 Long COVID factors: comorbidities, age, severity, inflammation, genetics13:50 Viral infection can trigger chronic inflammatory conditions.17:27 Long COVID linked to persistent antinuclear antibodies.22:53 Autoantibodies may form due to SARS-CoV-2 infection.27:28 Hepatitis B virus vaccine increases MS risk.33:58 Alphaviruses include herpes, 53% exhibit antibodies.39:30 Cytomegalovirus linked to autoimmune diseases, immune manipulation.45:39 Chronic Epstein Barr causes inflammation, cancer risk.52:02 Hepatitis C symptoms: diverse and system-wide impacts.57:33 High treatment costs spark global protests, denials.01:00:33 PCR measures viral load; biomarkers assess liver damage.01:06:08 Identify underlying health issues causing recurring infections.Support this show http://supporter.acast.com/solving-the-puzzle-with-dr-datis-kharrazian. Hosted on Acast. See acast.com/privacy for more information.

How genomics is shaping the future of cervical cancer screening[Content Warning: This episode mentions sexual assault and medical trauma.]Nearly 80% of people will get Human Papillomavirus (HPV) at some point in their lives. Even though HPV is super common, the symptoms are often subtle or invisible and can sometimes lead to cervical cancer if left undetected. But thanks to new government initiatives like British Columbia's (BC) self-screening program, cancer testing is levelling up.In this episode, BC resident Christina Price shares how an easy at-home HPV test helped her catch cancer early. Then, Dr. Aisha Lofters debunks persistent myths about HPV, and explains how these test kits are making screening more accessible, comfortable, and equitable. Join host Dr. Kaylee Byers to find out how this genomic tool is empowering people to take their healthcare into their own hands (literally!), and getting us closer to eliminating cervical cancer for good.If you, or someone you know needs support, you can call 1-800-563-0808 or find Canada-wide resources right here.–Highlights:(4:25) Christina talks about the steps that happen after receiving her result from the at home testing kit.(8:09) Dr. Lofters explains what HPV is, the symptoms and what differentiates different strains of HPV.(15:54) Dr. Lofters explains the two different methods for HPV screening(19:30) Dr. Lofters talk about some of the inequities and social barriers people face when finding and accessing healthcare.–Learn-A-Long: (coming soon)—Resources:1. Human papillomavirus - Women's Health2. Doctors say at-home screening for HPV could be an opportunity to 'eliminate a cancer sooner - CBC News3. New self-screening program will help detect cervical cancer sooner - BC Gov News4. Pap test - Canadian Cancer Society5. When a pelvic exam is traumatic - Harvard Health6. “Doing it on my own terms”: Transgender and nonbinary adults' experiences with HPV self-swabbing home testing kits - National Library of Medicine

Each year, 13 million Americans, including teenagers, become infected with Human Papillomavirus (HPV). Join us as we learn more about this virus and the only vaccine that can prevent cancer.

Human papillomavirus (HPV) is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer. Gardasil is a vaccine developed to protect against HPV infection. It is recommended for both males and females to prevent the spread of the virus and reduce the risk of developing related cancers. Gardasil is most effective when administered before exposure to the virus through sexual activity. The Gardasil vaccine is typically given in a series of shots over a period of six months. It is designed to target the most common strains of HPV that are known to cause genital warts and cervical cancer. The vaccine has been proven to be safe and effective in preventing HPV infection and its associated health complications. It is an important tool in reducing the prevalence of HPV-related diseases and promoting overall public health. In conclusion, Gardasil is a crucial vaccine in the fight against HPV and its consequences. By getting vaccinated, individuals can protect themselves from HPV-related health issues and contribute to the prevention of the virus in the community. It is recommended to consult healthcare providers for more information on the vaccine and its benefits.

Cervical cancer is the fourth most common cancer in women globally. It causes more than 800 deaths in the UK each year. Yet 99.8% of cervical cancer cases are entirely preventable. Regular screening and the introduction of the Human Papillomavirus (HPV) vaccination are helping to reduce the number of deaths. With smart policy and public health interventions NHS England have set 2040 as the target date for total elimination of cervical cancer. If that goal is to be met the issue of health inequality needs to be addressed; currently screening and vaccination rates vary between different regions, communities and socio-economic groups. So what needs to be done to share best practice and narrow these inequalities? In this episode of Spotlight on Policy, host Zoe Grunwald is joined by Emma Cerrone, Business Unit Director for Public Health & Vaccines at MSD; Dr Adeola Olaitan, Honorary Associate Professor at University College London and Honorary Consultant Gynaecological Oncologist at UCLH; and Gayathri Kumar, Senior Economist at OHE, the Office for Health Economics. This episode has been fully funded by MSD who, as sponsors, have reviewed and inputted to the final content. The report referenced by Office for Health Economics throughout this episode was fully funded by MSD. Ultimate editorial control for this episode and the OHE report rests solely with the New Statesman and the Office for Health Economics, respectively. MSD is one of the world's leading pharmaceutical companies active in several key areas of global health, including immunisation and oncology. Hosted on Acast. See acast.com/privacy for more information.

Dr. Brian Kriete, an ENT (ear, nose and throat) physician and medical director of surgical services with Phelps Health talks about Human Papillomavirus Virus or HPV related to head and neck cancer or thyroid cancer.

Pemerintah pada 2023 telah mencanangkan program nasional pemberian vaksin Human Papilloma Virus (HPV) gratis untuk anak sekolah kelas 5 dan 6 SD. Vaksin HPV merupakan vaksin yang dapat melindungi individu dari infeksi HPV, penyebab kanker leher rahim atau serviks dan kanker penis. Kanker serviks sendiri berada di urutan kedua yang menyebabkan kematian perempuan di Indonesia. Program pemberian vaksin HPV gratis bagi anak dilakukan untuk mencapai target pemerintah, yaitu 90% anak perempuan dan laki-laki di Indonesia mendapatkan vaksin HPV pada 2030. Target ini tertuang dalam Rencana Aksi Nasional Eliminasi Kanker Serviks Indonesia. Seperti apa progres pelaksanaan pemberian vaksin HPV gratis ini? Dan apa tantangannya? Di Ruang Publik KBR hari ini, kita akan berbincang dengan dr. Prima Yosephine Berliana, Direktur Pengelolaan Imunisasi Kementerian Kesehatan RI. *Kami ingin mendengar saran dan komentar kamu terkait podcast yang baru saja kamu simak, melalui surel ke podcast@kbrprime.id

This week we sit down with Jennifer Young Pierce, MD, MPH, FACOG to discuss her role, disparities in cervical cancer, and exciting advancements in her space. Dr. Jennifer Young Pierce is a Senior Staff Physician and Professor of Gynecologic Oncology at the University of South Alabama Mitchell Cancer Institute (MCI). She joined USA Health MCI in 2017 with national expertise in Human Papillomavirus (HPV), cervical cancer, and cancer disparities. She currently serves as the Division Director of Cancer Prevention and Control and an Abraham A. Mitchell Clinical Cancer Research Scholar.She is also the host of the podcast, The Cancering Show, seeking to demystify cancer with knowledge, hope, and humor for thousands of listeners. Most importantly, Dr. Pierce is deeply committed to the care of women with gynecologic cancers and spends the majority of her time seeing patients and performing radical surgeries for cancer treatment.  Dr. Pierce lives with her husband and two daughters in Mobile, Alabama.You can find more information on The Cancering Show here: https://cancering.com/

Have you ever wondered exactly what HPV is and why the HPV vaccine is so important? In this episode your Ob/Gyn friend and expert, Dr. Hack, demystifies Human Papillomavirus (HPV) and reveals the power of vaccination. Recorded live on TikTok, this episode offers a unique, interactive experience where listeners could engage in real-time questions, making it both educational and dynamic. Dr. Hack makes complex health topics easy to understand and engaging, emphasizing the critical role of vaccinations in preventive health.

Tingginya angka kejadian kanker serviks atau kanker leher rahim di Indonesia dipengaruhi oleh cakupan skrining yang masih rendah. Padahal kanker ini bisa dicegah dengan imunisasi vaksin Human Papillomavirus (HPV) dan deteksi dini. Di Indonesia, kanker serviks merupakan kanker paling banyak kedua yang dialami perempuan setelah kanker payudara. Di Asia Tenggara, Indonesia merupakan negara dengan insiden dan kematian tertinggi akibat kanker serviks yakni, 24,4 per 100 ribu penduduk dengan kematian 14,4 per 100 ribu penduduk. Karena itulah pemerintah telah mencanangkan Rencana Aksi Nasional Eliminasi Kanker Serviks Indonesia (2023-2030). Apa yang harus dilakukan agar program ini berjalan lancar? Kita bincangkan hal ini bersama dua narasumber yang telah bergabung di Ruang Publik KBR pagi ini. Ada dokter Widyorini Lestari Hutami Hanafi, Ketua Timja Kanker Ginekologi Pusat Kanker Nasional RS Kanker Dharmais dan Shanty Eka Permana, Survivor Kanker Serviks dari Cancer Information and Support Center (CISC). *Kami ingin mendengar saran dan komentar kamu terkait podcast yang baru saja kamu simak, melalui surel ke podcast@kbrprime.id

Laura Dowling talks to Nicky Halliday, nutritionist and natural chef about life and discovery through the psychedelic experiences of the Ayahuasca ceremony, following your inner beliefs and emotions, and taking action from a place of love! Long time sufferer of the HPV virus Nicky talks openly about the advances and development of AHCC Mushrooms and the diagnosis, treatment, and lifestyle practices around the treatment and acceptance of the Human papillomavirus (HPV) as an alternative to the traditional treatment from doctors called the LLETZ procedure.Nicky, who is based in Ireland now offers other women support with their cervical health, and acceptance of the HPV virus and runs traditional Cacao Ceremonies for women. To find out more about Nicky Halliday, visit her YouTube channel  @nickyhalliday1 or visit her website https://nickyhalliday.com/To find out more information about fabuwellness and Laura Dowling please visit https://fabuwellness.com

We have the distinct pleasure of sitting down and chatting with the esteemed Dr. Pooja Mehta.Pooja K. Mehta, MD, MSHP, is a board-certified practicing obstetrician gynecologist, and head of women's health at Cityblock Health, the first Medicaid-focused, value-based, tech-enabled provider for communities with complex health and social needs.In this episode we dive all the way in on Human Papilloma Virus (HPV) and talk about the myths, transmission, and why the vaccine came to be such a big deal for humans of all genders and young ages.  You don't want to miss this even if you are a clinician, she teaches us all how to speak clearly and eloquently about this infection.https://www.cdc.gov/hpv/parents/vaccine-for-hpv.htmlShared Harvest Fund:https://www.sharedharvestfund.org/Check out our Youtube Channel:https://www.youtube.com/@helpmakeitmakesense6769/videosShout out to Jeff Jeudy to providing the music!

Have you ever considered the critical link between oral health and your overall well-being, particularly in relation to oropharyngeal cancer? Are you aware of how the Human Papillomavirus (HPV) could be silently impacting your health, and the vital role early detection plays? In this enlightening episode of me&my health up, host Anthony Hartcher is joined by Dr. Mohammad Kamal, a renowned expert in pathology, to delve deep into the intricate world of HPV and its undeniable connection to oropharyngeal cancer. Dr. Kamal sheds light on the silent nature of HPV, explaining how this prevalent virus can reside in the body for years without showing any symptoms, yet have a profound impact on one's health. Discover the importance of early detection and the proactive steps you can take to protect yourself and your loved ones. Dr. Kamal emphasises the crucial role dental professionals play in identifying early signs of oropharyngeal cancer, highlighting the need for regular dental check-ups and open conversations about HPV and its associated risks. Tune in to empower yourself with knowledge and learn why HPV awareness is more crucial than ever. Don't miss out on this opportunity to take a proactive stance in your health journey and contribute to the global fight against oropharyngeal cancer.  About Dr, Mohammad Kamal:  Dr. Mohammad Kamal holds the esteemed positions of Founder and Chief Executive Officer at Omnipathology. He is board certified in Anatomic Pathology and is renowned for his subspecialty expertise in Gastrointestinal and Liver Pathology. Completed his Pathology training at Harbor UCLA Medical Center in Torrance, California, where he also served as a chief resident. He further honed his skills and knowledge through subspecialty fellowship training in Gastrointestinal and Liver Pathology at UCLA. Dr. Kamal has an extensive and impressive career, having managed large national pathology laboratories. He served as the Medical Director of LabCorp's Dianon Laboratory and as Chief Medical Officer for PLUS Diagnostics. He is recognized as an expert in laboratory quality, with a stellar track record of developing quality systems and guiding laboratories to achieve CLIA, CAP, and New York State accreditations. Dr. Kamal has a particular interest in colon cancer, Barrett's esophagus, and inflammatory bowel disease. He is a frequent lecturer at medical schools and conferences, both in the United States and internationally. His commitment to education and healthcare is evident through his voluntary work as a Clinical Assistant Professor of Pathology at UCLA. Connect with Dr. Mohammad Kamal and OmniPathology:  Website:    https://www.omnipathology.com/ LinkedIn:    https://www.linkedin.com/company/omnipathology-medical-solutions/ Facebook: https://www.facebook.com/OmniPathology/ Instagram: https://www.instagram.com/omnipathology/ Youtube:    https://www.youtube.com/@OmniPathology  About mePodcast DisclaimerAny information, advice, opinions or statements within it do not constitute medical, health care or other professional advice, and are provided for general information purposes only. All care is taken in the preparation of the information in this Podcast. [Connected Wellness Pty Ltd] operating under the brand of “me&my health up”..click here for moreSupport the show

Men of Movement - In Person Retreat, Nov. 10-12thmikesalemi.io/menofmovementretreatWelcome to The Path podcast, where we tackle a subject that often remains in the shadows – HPV (human papillomavirus) and sexually transmitted infections (STIs). While it's typically associated with women, we're about to unveil the whole truth, and it's a revelation that applies to both men and women. In today's discussion with the insightful Mimi of the Medicine podcast, we're breaking down misconceptions, blame, and shame around HPV and STIs. We're leaving no stone unturned, exploring how these affect both genders and relationships. Plus, we're delving into holistic health practices for women and how men can be supportive partners. This is a conversation you don't want to miss, so let's dive in with Mimi.Timestamps00:00 Intro02:52 Human Papillomavirus (HPV)09:47 What Does AHCC Stand For?11:58 Some Of The Stigmas Around STI17:31 Getting Into Details Of HPV Statistics22:25 Are Most Men Asymptomatic Of HPV?25:11 How To Notice If You Got HPV28:23 How Self-Confidence Relates To HPV Diagnostic34:03 How Can Men Support Their Partners With HPV43:16 Traditional Approaches To Support Women With HPV47:00 LEEP Procedure50:17 How Else Is Mimi Battling HPV?56:00 Deliverables From Participating In The Program58:39 Final CommentsMike Salemiwww.Mikesalemi.ioInstagram: @Mike.SalemiMimi LindquistCLEAR + FREE Waitlist receive a free 30 min call with Mimi or Dr. Nathan Riley)Start Clearing HPV Today - Free ResourceMushroom Products - Immune Intel AHCC + MushyLove LatteInstagram: @mimi_themedicin

Kristin spoke with Dr Terri Foran to discuss Human papillomavirus (HPV). We covered: the HPV vaccine genital warts cervical cancer  changes to National Cervical Screening Program (pap smears)  

About MimiMimi is a Culinary Nutrition Expert, AHCC advocate educator, and Host of The Medicin Podcast. She has been helping people prevent disease for over 10 years now by educating and empowering individuals to be their own health advocates. Unfortunately, there is a significant gap between the clinical research of mushrooms and the general public, so Mimi is committed to being the link between research and the public via online education, social media, and her podcast, The Medicin.Recording Date: September 26, 2023Mimi's LinksIG: @mimi_themedicinMushroom Products: https://www.themedicin.com/productsUse Discount Code "CLAYTON" for 10% off everything in store!HPV CLEAR + FREE Program Waitlist: Join Here!Clear HPV Free Resource: Free DocumentClayton's LinksFree 999 Meditation Challenge: https://999meditation.travelingtoconsciousness.com/Website: travelingtoconsciousness.comBook: travelingtoconsciousness.com/rstj-got-volume-1Support the Show & become a Podcast Producer: https://patreon.com/travelingtoconsciousnessAI Description Of EpisodeWhat if you discovered a potentially life-saving dialogue that's often brushed under the carpet? We're shining a light on that very topic: The Human Papilloma Virus (HPV). It's not just a medical term, it's a reality that 80% of women and 90% of men who are sexually active will encounter at some point. We're blowing the lid off mainstream narratives about HPV, its connection to cervical cancer, and the effectiveness of the HPV vaccine.Feeling lost in the dense forest of guilt, shame, and blame that often trail an HPV diagnosis? You're not alone. Teaming up with our guest expert, we're empowering you with knowledge to navigate this emotional landscape. Wisdom is indeed bliss, and ignorance can be painful. We're handing you the torch to light up the dark corners of HPV misinformation, and offering tools to help regain control.Lastly, we're stepping into the power of a healthier lifestyle and the importance of owning your authentic voice. We've researched the potential of AHCC, a mushroom extract, in treating persistent high-risk HPV. A study conducted by Dr. Judith Smith of Texas showed promising results. But remember, a holistic approach to health is crucial.  Timecodes(00:00:00) - Understanding HPV(00:05:21) - HPV Education and Mainstream Frustration(00:22:58) - Navigating HPV(00:34:58) - Authentic Voice and Health Connection(00:42:19) - Choose Hard, Step Into Power(00:48:03) - AHCC Benefits for Clearing High-Risk HPV(00:56:22) - Mimi's Message to YOU!Intro/Outro Music Producer: Don KinIG: https://www.instagram.com/donkinmusic/Spotify: https://open.spotify.com/artist/44QKqKsd81oJEBKffwdFfPSuper grateful for this guy ^Support the showFREE 999 Meditation Challenge: https://999meditation.travelingtoconsciousness.com/Become a Podcast Producer: https://patreon.com/travelingtoconsciousness

Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In a new Voices of UMass Chan podcast episode, Grace Ryan, PhD, assistant professor of population & quantitative health sciences, discusses her research into vaccine hesitancy, particularly the parallels between the Human Papillomavirus (HPV) and COVID-19 vaccines rollout.

Suzanne Irene Pastore, M.D. discusses what patients should know about Human Papillomavirus (HPV). She discusses the impacts of HPV as the most common sexually transmitted infection (STI) in the United States. She also goes over how it is tested through the pap smear, which was developed by Dr. George Papanicolaou during his time at Cornell University Medical College's Department of Anatomy. She highlights the importance of vaccination for teens and adults in the prevention of certain strains of HPV. She also emphasizes why it's important for parents to have honest conversations with their kids and the doctors about the importance of getting vaccinated to prevent cancer.To schedule with Suzanne Irene Pastore, M.D.: https://weillcornell.org/suzanne-irene-pastore-md 

Vi fortsætter sommerens serie om virus med professor Anders Fomsgaard fra Statens Serum Institut. Den seneste globale COVID-19 pandemi har skabt interesse for at forstå virus bedre. Der er rigtigt meget at fortælle, også en del overraskende ting som for eksempel, at vi har store mængder virus indbygget i vores genom. Der findes virus som angriber virus. Nogen virus er måske ligefrem gavnlige for vores immunsystem andre slår dig ihjel på kort tid. Professor Anders Fomsgaard gør status over, hvad vi ved og ikke ved om virus i en serie interviews med videnskabsjournalist Jens Degett. Serien består af fem programmer som blev optaget onsdag den 11. marts og fredag den 13. marts 2020. Det sidste program blev optaget den 15. april 2020. Dette program handler om mæslinger, som er mange gange mere smitsom end Corona virus. Der er en meget spændende historie om Peter Aaby's observationer i Gunea Bisau, HPV virus, som har skabt en kæmpe debat om vaccine og Herbes som måske ikke et så ringe endda. Anders Fomsgaard har været leder af Virus Forsknings & Udviklingslaboratoriet på Statens Serum Institut siden 1992. Han er desuden adjungerende professor ved SDU, og har arbejdet med virusforskning i Danmark, Tyskland og USA. Anders Fomsgaard er desuden aktuel med en bogudgivelse med titlen: ”Det er bare en virus”, udgivet på Gyldendals Forlag. Næste podcasts i serien: Virus i perspektiv 4: Eksotiske kæmpevirus og virus i vores genom Foto kredit: Jens Degett, © Science Stories ApS.

In this episode of "Matter of Vax" podcast, host Steph O'Connell interviews Professor Julia Brotherton, a public health physician and professor of cancer prevention policy and implementation. They discuss the human papillomavirus (HPV), its link to cancers, the importance of vaccination and its impact on cervical cancer's global footprint. The HPV vaccine, developed by Australian scientists, has proven highly effective in preventing infection and related diseases. The vaccine has had a significant impact in Australia and globally, reducing genital warts and cervical precancerous cases. It also protects against other HPV-related cancers, such as anal and head and neck cancers. Professor Julia Brotherton highlights the importance of the vaccine in preventing cancer, its efficacy and successful implementation worldwide.   Visit Immunisation Foundation of Australia for more information For more episodes of Matter of Vax, visit https://www.ifa.org.au/matterofvax Host Steph O'Connell is a public health advocate with 25 years' experience in strategic communications. She became a public voice for vaccinations when her daughter, Lily (23), narrowly survived W strain of Meningococcal on Christmas Day, 2017. Nine months later her sister, Grace, donated a kidney that has since transformed Lily's life.  Steph's advocacy for immunisation awareness and vaccination became a collaboration in 2018 with Meningococcal Australia and resulted in Meningococcal vaccination campaigns by the Australian Government Department of Health and NSW Health. Lily's story quickly resonated with audiences and became a national and international appeal for awareness, education and vaccination.  Steph's work expanded during the pandemic and today she continues to advocate for improved access to vaccines, public education for lifelong vaccination behaviour and policy reform. MatterofVax, in collaboration with Immunisation Foundation of Australia takes a look at topical immunisation issues on video and podcast.  Listen to Matter of Vax on Apple.  Matter of Vax is produced by Ampel, for Immunisation Foundation of Australia. See omnystudio.com/listener for privacy information.

Did you know that Human Papillomavirus (HPV) is among the leading causes of head and neck cancer in men? Did you also know that many more of us will contract HPV based on the number of strains? In this week's episode of Gent's Talk, the Gents sit down with Dr. Jia Hu where he breaks down the affects of HPV, the large number of men who will contract it and more importantly, how to fight against it. *This episode is sponsored by Merck - Any opinions expressed in this episode are those of the healthcare professional alone & do not necessarily reflect the views, opinions, policies or position of the episode sponsor.* #gentstalk About Gent's Talk: The Gent's Talk series, powered by Gent's Post and presented by BULOVA Canada is an episodic podcast/video style conversation with the leading gents and rising stars of industry. Guests on the show thus far include Russell Peters, Jonathan Osorio, Wes Hall, Karl Wolf, Diogo Snow, Nick Bateman, Justin Wu and many more. The conversations range from career, mental health, family, relationships, business, and everything in between. Even more excitingly, Gent's Talk is the first ever podcast in video format to be featured on all Air Canada domestic/international flights. Our intention is to have a raw and unfiltered conversation with our guests about their lives, how they achieved their successes, lessons learned along the way, and the challenges of climbing that mountain. About Dr. Jia Hu: Dr. Jia Hu is a public health and preventive medicine specialist physician and the CEO of 19 To Zero, a not-for-profit aimed at encouraging health behaviour change around issues like vaccines, cancer screening, and chronic disease management. He is also a physician with Cleveland Clinic Canada and the Corporate Medical Director for the Canadian Pension Plan Investment Board. Dr. Hu has earned several academic achievements, including a BA in Economics from Harvard University, an MD from the University of Alberta, and a master's degree from the London School of Economics & London School of Hygiene & Tropical Medicine. Connect with us! Website: https://gentspost.com/ Instagram: https://www.instagram.com/gentspost/... Tik Tok: https://www.tiktok.com/@gentstalkpod Twitter: https://twitter.com/GentsPost Facebook: https://www.facebook.com/gentspost CREDITS: Host/Producer: Samir Mourani Co-Host: Matthew Chapman Creative Director: Steven Branco Video & Sound Editor: Roman Lapshin Video & Sound Technician: Poncho Navarro Studio: Startwell Studios A STAMINA Group Production, powered by Gent's Post.

Dr. Leone is a leader in the treatment and research of Human Papilloma Virus (HPV), Herpes and HIV. He also loves to cook and has a great sense of humor. He shares his insights on STDs, pandemics and the best in Italian cooking.

Professor Ian Frazer pioneered the development of the first Human Papilloma Virus (HPV) vaccine which has seen a reduction of HPV infections in young women between 70-86% and the incidence of cervical cancer rates drop by 90%. Few doctors/scientists have had such a profound impact on the health of so many people. Today we talk to Professor Ian Frazer about his career, the events leading up to the HPV vaccine development, and the future of this life-saving medicine. Some of Professor Ian Frazer awards include: Australian of the Year (2006) Prime Ministers Prize for Science (2008) The Balzan Prize (2008) Fellow of the Royal Society of London (2012) Companion of the Order of Australia on the Queen's Birthday Honours list (2013) Immunology research department named the Frazer Institute at the University of Queensland This is the Story of Professor Ian Frazer and the development of the cervical cancer vaccine.See omnystudio.com/listener for privacy information.

Hosts Chris Joyce and Stephanie Winn sit down with Dr. Julie Dang of the UC Davis Comprehensive Cancer Center. Dr. Dang is the Executive Director of the Office of Community Outreach and Engagement and is co-chair of the California HPV Vaccination Roundtable's Engaging Health Systems and Providers Workgroup. Dr. Dang is also a cancer health disparities behavioral researcher with over a decade of experience engaging diverse and underserved communities in cancer control and prevention. To learn more about the UC Davis Comprehensive Cancer Center, visit https://health.ucdavis.edu/cancer.

A cervical cancer screening study will give its participants the option to test at home.  The study will look at the impacts of the Human Papillomavirus (HPV) test, which will be Aotearoa's main screening method for cervical cancer from next year.  About 3,000 participants will be able to choose whether to have their test at their doctor's surgery or do it themselves from home.  University of Otago, Christchurch, associate professor Peter Sykes spoke to Māni Dunlop.   

Six out of ten Americans have been diagnosed with one or more chronic illnesses, according to the Center for Disease Control and Prevention. While this statistic may seem shocking, even more astounding is the lack of research into common diseases, such as Lyme Disease, that Oakley's client lives with every day. Many people don't know that inflammation in the body can create overwhelming anxiety. Because of a lack of understanding of the connection between these symptoms, people with chronic illness diagnoses are often left untreated or even worse, gaslighted about the very real nature of what they're experiencing. As Oakley reminds her clients and listeners, the physical body is intimately connected with the mental, emotional and spiritual health of an individual. In this episode, she digs deeper with her client into some of the familial patterns that may have played a role in the physical expression of her disease. Healing generational trauma begins with awareness. This resilient young woman was able to identify unhealthy patterns such as body shaming, codependency, and emotional manipulation within her family relationships and has made choices to set appropriate boundaries. Taking back control of her life has increased her self-esteem and given her the confidence she needs to move forward with healthy relationships with friends, her partner, and most importantly, herself. Main Topics Oakley's client discusses her chronic illness diagnoses of Lyme, Labisia, and Chronic Inflammatory Response Syndrome (CIRS) (2:06) The definition of gaslighting and how to validate your own experiences (12:30) The connection between disease and anxiety (18:55) Trigger Warning: Oakley's client shares about her early teenage years when she felt suicidal and struggled with self-harm (23:03) How caretaking can easily become a person's identity, leading to codependency (31:05) Education about sexual health and various strains of Human Papillomavirus (HPV) for female-bodied individuals (40:50) Conscious coping mechanisms and setting boundaries (49:10)   Episode LinksThe Body Keeps the Score- Bessel van der KolkBetterhelp.comPsychologytoday.com Want to learn more or apply to be a guest on Sex, Drugs and Enlightenment?Check out the website!https://www.sexdrugsandenlightenment.comConnect with Oakley:https://oakleyogden.comhttps://www.instagram.com/oakleyogden/https://www.linkedin.com/in/oakley-ogden-7a86b112/https://www.youtube.com/channel/UCxn6BnlaAAK_i9utOIg2KOQListen, rate, and subscribe!

Katie Dollar, PharmD, Clinical Staff Pharmacist at Price Chopper Pharmacy returns to the Quality Corner Show to provide immunization updates on Human Papillomavirus (HPV) and rounds out a set of August Immunization Awareness Month episodes.In this episode, podcast host Nick Dorich, PharmD, PQS Senior Manager of Pharmacy Accounts asks Dollar about HPV guidelines, prevalence, risk factors and historical prevention efforts. Dollar reminds pharmacists to check with their state board of pharmacy and pharmacy practice laws in determining whether they can administer the vaccine and to which qualified patients in their state. 

The Cervivor Podcast is a platform built for sharing and elevating our stories. Tune in to hear more about our Season 2 podcast host, Joslyn Paguio. Become inspired, learn more about the Human Papillomavirus (HPV), cervical cancer, and hear how Joslyn has used her personal experience to educate others. Beyond the podcast, read Joslyn's Cervivor story on our website or watch her story on our award-winning YouTube channel, Cervivor TV. Join in the conversation by using #CervivorPodcast. Let us know what you think! For more Cervivor-related content, check out: Cervivor.org. Follow Cervivor on all social media platforms. If you would like to be interviewed as a potential guest for an upcoming episode or would like to request a speaker or topic for a future podcast episode, email us at info@cervivor.org.

My name is Advait and I’m a recent Molecular Biology graduate, and currently in the Accelerated Masters Program (AMP). For the past 3 years, I’ve worked in the Campos Lab at the Bio5 institute, where we study Human Papillomavirus (HPV)— the leading cause of ~90% of cervical cancer cases. My current research projects involve the anti-viral enzyme known as cGAS (cyclic GMP-AMP synthase) that is a DNA sensor which binds DNA and stimulates an immune response. It’s a very cool enzyme, and I hope to figure out how HPV is stifling its function because we have some evidence suggesting that. In my spare time, I love to play soccer, but also recently got into basketball (since no one plays soccer in AZ in the summer).

Guest: Dorcas Nhlapo 

This episode features Alissa G. Yeargin, MSR, CCC-SLP, a specialist in the evaluation and treatment of adult and adolescent voice, upper airway, and swallowing disorders, and rehabilitation of communication and swallowing for patients with head and neck cancer. HPV oropharyngeal cancers are most commonly seen in the tongue base and tonsils. Alissa discusses the rise of oropharyngeal cancers related to the Human Papilloma Virus (HPV). In addition, this episode discusses what HPV is, how it can be prevented, and the SLP's role in evaluating and treating patients who have been diagnosed with oropharyngeal head and neck cancer.

HighlightsIntroduction: The data on maternal health | Callie and Stacey continue the focus on equity and our health with a look into the state of maternal health care, including reports from the CDC on pregnancy-related deaths.04:21 Roundtable: Redefining maternal care | Dr. Natalie Hernandez of the Morehouse School of Medicine and Ryan Adcock of Cradle Cincinnati talk about public health, the history of maternal care, and what changes they're seeing make a difference.16:47 Cradle Cincinnati | Callie and Ryan dig deeper into the work that Cradle Cincinnati is doing—and how it illustrates the idea that maternal health needs to be considered in the context of a person's identity and broader social context.23:15 Conclusion | To wrap up the episode, Callie and Stacey reflect on what their guests shared. Of particular note is the idea of diverse and inclusive care practices, which we'll take a closer look at in Episode 3. Resources mentionedCDC research: Pregnancy complicationsThe challenge to improve U.S. maternal healthCradle CincinnatiPress release: Optum Awards $1.4 Million in Maternal Health Grants to Five Community Organizations GuestsDr. Hernandez's current research and research interests include transdisciplinary approaches to improving women's health, reproductive health, sexually transmitted infections, health disparities, community-based participatory research, and reproductive social justice. Dr. Hernandez's research and interests stem from her commitment to health equity and improving health in underserved communities. During her doctoral program, she worked on multiple projects including behavioral and psychosocial health issues related to women's health, HPV, and sexuality education. Dr. Hernandez was a HRSA maternal and child health leadership trainee and epidemiology trainee. In addition, she is a lead investigator on a study focusing on psychosocial and socio-cultural correlates of Human Papillomavirus (HPV) vaccine intentions and uptake among minority college students and her dissertation focused on examining multiple factors that contribute to the meaning and perceived consequences and management of an unintended pregnancy among Latinas. As a result of her work, she has received a number of awards and published a variety of articles in peer-reviewed journals. Ryan Adcock is the executive director and co-founder of Cradle Cincinnati, a network built with the express purpose of reducing the high infant mortality rate in Hamilton County. In the eight years since its founding, Cradle Cincinnati has raised more than $25 million for its cause and built dozens of partnerships within the community to save lives. His work for Cradle Cincinnati has included community engagement, strategic planning and evaluation, and communications and media strategy. The result to date—among many other positive outcomes—has been a 15% decline in Hamilton County infant deaths. The views, opinions, and content expressed in this presentation do not necessarily reflect the views, opinions, or policies of Optum.

We talk with Dr. Andrew Day about the Human Papillomavirus (HPV) and Oropharyngeal Cancers. --- CHECK OUT OUR SPONSOR Edward Jones https://www.backtable.com/401k --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs: https://earnc.me/enhhq6 --- SHOW NOTES In this episode, head & neck surgical oncologist Dr. Andrew Day joins Dr. Gopi Shah and Dr. Ashley Agan in discussing the screening, treatments, prevention, and current research over HPV-positive oropharyngeal cancers. We begin by discussing the ubiquitous Human Papillomavirus (HPV) and identifying high-risk strains. While there is still a lot of research to be done over this virus, Dr. Day describes the estimated prevalence of HPV in the adult population and available screening methods. He brings up the possibility of latent infections and differences in individuals' immunogenic responses. Moving into HPV-mediated cancers, Dr. Day distinguishes HPV-positive from HPV-negative head & neck cancers and discusses the differences in presentation and treatment for each type. HPV-positive oropharyngeal cancers usually present as neck masses with no other clear risk factors, and they can be confirmed through ultrasound-guided fine needle aspiration biopsy. Treatment options include various combinations of transoral robotic surgery, transoral laser microsurgery, chemotherapy, and radiation. Finally, we discuss patient education over HPV and its associated cancers. We address patient inquiries about tonsillectomy as a preventative measure, advice for partners/spouses of HPV-positive cancer patients, and otolaryngologists' role in raising awareness of the HPV vaccine (Gardasil 9). --- RESOURCES CDC HPV Vaccine Recommendations: https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html

Human Papillomavirus (HPV)

How a scientific breakthrough led to the invention of the revolutionary cancer vaccine. In the 1980s, it was established that cervical cancer was caused by the Human Papilloma Virus (HPV) which is usually spread through sexual intercourse. In 1989, scientists Ian Frazer and Jian Zhou at the University of Queensland began working on the basis of a possible vaccine for HPV Their solution was to use parts of the virus's own genetic code to create a virus like particle (vlp) which would trigger an immune response. Alex Last has been speaking to Professor Ian Frazer about their discovery.(Photo: Electron micrograph of virus like particles formed from the outer protein coat of the human papillomavirus (HPV). The proteins form a virus-like particle that does not contain any genetic material. Credit: Science Photo Library)